The 75% Quarter That Grew Faster Than Its Profit
Fabtech delivered record-breaking 75% revenue growth and a ₹468 Cr order book in H1 FY27, but PAT grew only 55% and margins stayed flat at 7.7%. The earnings call reveals why profitability lagged—and why the market repriced -34.7% from all-time highs.
Fabtech Technologies delivered the headline that markets might have craved—a ₹133 Cr quarter (75% revenue growth) and a record ₹468 Cr order book (2.3x since March). Yet the company's earnings call revealed an uncomfortable truth: profitability lagged volume dramatically. PAT grew only 55% despite 75% revenue expansion. EBITDA margin stayed flat at 7.7% despite scale. This is not the margin-expansion story of a business scaling elegantly; this is a business executing growth under margin pressure. The street noticed: FII exited completely to 0%, and the stock repriced -34.7% from its all-time high of ₹575 to ₹375.5 (as of Nov 5, 2026).
₹133 Cr
+75% YoY | Standalone ₹107 Cr (+41% YoY)
₹5.15 Cr
+55% YoY | Growth lagged volume by 20 points
7.7%
Flat vs prior H1 | Expected improvement didn't materialize
₹468 Cr
2.3x vs Mar26 | But ~₹40 Cr gap to H1 execution
Where the gap came from
Revenue scaled 75%, but cost pressures and execution constraints throttled profit growth. Raw material inflation hit hard—aluminum prices jumped from ₹220 to ₹440 in just two months. Reference projects, like the Awaree Solar cleanroom build, were deliberately taken at lower margins to establish credentials with multinationals. And the Hyderabad facility was ramping, absorbing setup and absorption costs. Management stated: 'This year we were hit with geopolitical conflicts, broken supply chains, material costs swinging week to week. Never before has the metal market been so unpredictable.' The math is stark: 75% revenue growth absorbed by input inflation, reference-project margin sacrifice, and operating leverage headwinds meant PAT grew only 55%—a 20-point divergence between headline and profit growth.
The order book paradox: ₹468 Cr that didn't execute
Analysts immediately pressed on the order book mechanics. Opening ₹199 Cr + new orders ~₹517 Cr declared = ₹716 Cr supply, but closing book was ₹468 Cr. Where did ₹248 Cr go? The answer revealed the quarter's real story. Approximately ₹40 Cr was 'execution slippage'—orders that should have converted to H1 revenue didn't. Management disclosed: 'Customers are not ready to accept deliveries despite design finalization. Their buildings are still under construction.' Translation: the order book is stuffed with conditional orders—not firm sales awaiting production runs, but design-finalized orders held back by customer capex timing. H1 execution was ~₹130 Cr revenue on a ₹468 Cr book (28% conversion rate), revealing bottlenecks in either delivery capacity or customer acceptance readiness. This is not fraud, but it is a flag for order quality and execution constraints.
Revenue grew 75% in H1
₹133 Cr vs ~₹76 Cr prior H1 = 75% confirmed
Supported
PAT growth 55%+ in H1
₹5.15 Cr vs ~₹3.3 Cr prior H1 = ~55% confirmed
Supported
EBITDA margin 7.7%, maintained vs prior H1
₹10.28 Cr / ₹133 Cr = 7.7% correct, but flat not improved despite scale
Supported (but margin lagged expectations)
Order book doubled to ₹468 Cr
₹468 Cr at Sep-30 vs ~₹200 Cr in Mar = 2.3x growth (not 2x)
Slightly overstated
Margins to improve in H2
Management stated 'PAT in H2 to exceed H1 fairly substantially' but drivers unclear given geopolitical inflation pressure; contingent on order execution & new order mix
Overstated (proof pending)
What changed on this call
Internal guidance revised sharply upward—external guidance stayed cautious. Prior quarters guided to 20-30% FY27 growth. The H1 order book acceleration to ₹468 Cr (and actual 75% H1 revenue delivery) prompted management to internally reframe: now targeting 70-80% FY27 growth internally, but continuing to guide the market conservatively to 20-30% for H2. This gap between internal conviction and external communication is notable: management is signaling bull conviction internally while maintaining bear-case optionality externally. A hedging move that creates credibility questions.
Margin outlook flipped from implicit expansion to caution. Prior earnings hinted at margin improvement from scale. H1 delivered 7.7% EBITDA margin (flat vs prior year), prompting management to reset expectations downward: internally targeting 8-10% PAT margins, but externally stating 'same as H1 (7.7%) going forward.' The ambiguity created analyst frustration—internally optimistic, externally hedged. When management says both things simultaneously, neither is credible until proven.
Data center and semiconductor elevated as high-margin growth levers. Management pivoted strategic emphasis toward India Semiconductor Mission (12 approved fab projects) and data center cleanrooms (Kelvin partnership, ₹120 Cr pipeline). These verticals carry higher margins than legacy pharma and commoditized solar reference projects. Implication: FY27 margin recovery depends not just on input cost stabilization, but on a deliberate shift in order mix toward higher-margin verticals.
The working capital trap
Receivables of ₹129 Cr represent 97% of H1 revenue (₹133 Cr). For project-based businesses, milestone-linked collections are normal, but this ratio is tighter than most. Management tied collections to project milestones and promised improvement by Mar 2027. October collections started, but near-term cash flow remains compressed. The company is funding growth with working capital leverage: strong order book, tight cash conversion. As long as collections track management's timeline and new orders maintain momentum, this is sustainable. If collections slip or growth stalls, cash runway becomes constrained.
How the market is positioned
The stock repriced -34.7% from its all-time high of ₹575 to ₹375.5 (as of Nov 5, 2026). It sits below SMA20 (₹436.57) and SMA50 (₹453.27), though above SMA200 (₹357.09). RSI at 36.6 suggests neutral momentum, but volume is increasing—a sign of either capitulation or accumulation breaking hands.
Institutional flows have turned decisively negative. FII ownership dropped to 0% (from 0.69% in FY25 Q4), a complete exit. DII reduced from 8.97% (FY26 Q2) to 5.65% (FY26 Q4)—a 3.32 percentage point outflow. Only promoter ownership (68.49%) remains stable. The institutional pullback reflects caution on margin recovery and execution risk—exactly the tensions this quarter surfaced.
This repricing may be overcorrected. Fabtech is executing a bold strategy: ₹468 Cr order book, 75% H1 growth, ₹50k sqm Hyderabad facility now operational. Long-term ambition—₹1,000+ Cr revenue by 2030, 25-30% market share by FY30—is credible given the cleanroom market is growing 50-70% annually. But the near-term margin recovery is unproven, the order book quality is conditional, and working capital is tight. At ₹375.5, the market is pricing in execution failure on all three fronts. If management delivers H2 milestone collections, order book conversion, and even flat margins into FY28, the risk/reward tilts favorable. Until then, caution is warranted.
The bull-bear ledger
Order book 2.3x in 6 months; largest in company history (₹468 Cr)
Revenue growth 75% outpaced guidance by 2.5x; demonstrates execution capability
Cleanroom market growing 50-70% annually; Fabtech targeting 25-30% market share by FY30
Data center (Kelvin ₹120 Cr pipeline) & semiconductor (India Semiconductor Mission) add high-margin growth levers
Hyderabad 50k sqm facility operational; automation-enabled manufacturing ready for scale
PAT growth (55%) significantly lagged revenue growth (75%); profitability didn't scale
EBITDA margin flat at 7.7% despite 75% growth; expected improvement didn't materialize
Order-to-execution gap of ~₹40 Cr reveals orders are conditional, not firm sales
Working capital burden: ₹129 Cr receivables = 97% of H1 revenue; collection risk near-term
FII exited completely (0%); DII trimmed 3.32pp; institutional sentiment turned negative
Margin guidance ambiguous: internally 8-10% target, externally 'same as H1' (7.7%)
Competition from Japanese (Daikin, ₹1,300 Cr revenue) and emerging European players intensifying
Margin compression may persist into FY28
HighH1 margins flat at 7.7% despite 75% growth; PAT grew only 55% of revenue growth rate. If reference projects drag longer or input inflation persists, FY27/28 profitability growth will remain capped well below revenue growth, destroying valuation upside.
Order book quality contingent on customer building readiness
High₹468 Cr order book, but ~₹40 Cr slippage vs H1 execution revealed orders are conditional. If customer capex cycles slow or construction delays accumulate, order-to-revenue conversion may miss H2 targets. FY27 guidance (70-80% internal) depends on executing this book.
Working capital may not improve by Mar 2027 as promised
Medium₹129 Cr receivables (97% of H1 revenue) tied to milestone-linked collections. If reference projects slip, collection timeline extends. Cash flow tightens, limiting capacity to fund H2 growth or fund capex. Capex for expansion remains unquantified.
Competitive entry from Japanese/European players accelerates
MediumDaikin (₹1,300 Cr annual revenue) and emerging European entrants see the same 50-70% cleanroom market growth that excites Fabtech. Intense competition on price/terms could accelerate margin compression in new orders, offsetting mix improvement.
Geopolitical supply chain volatility persists
MediumAluminum prices swung 100% in 2 months (₹220→₹440). If geopolitical tensions continue, input cost volatility remains unpredictable. Management hedging through customer contracts is reactive, not proactive. Risk of surprise margin hits persists.
Capex requirements unquantified; may require external financing
Low-MediumManagement stated capex 'under discussion' and banks have 'enhanced credit lines' but no guidance given. Growth target of 70-80% FY27 + ambition to reach ₹1,000+ Cr by 2030 requires significant capex. If cash generation disappoints, external equity dilution risk rises.
What to watch next
1 · H2 order book execution and revenue delivery (₹200+ Cr expected)
The critical de-risker. If management delivers ₹200+ Cr H2 revenue from the ₹468 Cr order book, it proves order quality and manufacturing capacity are improving. Confirms 70-80% FY27 growth is achievable.
2 · Milestone-linked receivables collections by Mar 2027
Management promised collections would improve as reference projects complete. If receivables fall below 80% of quarterly revenue by Mar, working capital normalization is confirmed, freeing cash for capex.
3 · H2 EBITDA margin trend—improvement or further compression?
The real profitability test. If H2 EBITDA margin improves to 8%+ (vs H1 7.7%), it validates management's margin recovery narrative. If flat or lower, the margin headwind story persists into FY28.
The debate
The honest read: Fabtech is a long-term compounder executing a bold strategy in a genuinely growing market. Management is competent and honest about challenges (acknowledged execution constraints candidly on the call). But the quarter revealed a business growing faster than it's learning to profit—a classic scaling challenge. Near-term risks (margin recovery, working capital, order execution) are material. The bull case requires all three to resolve favorably by Mar 2027. The bear case requires any one to slip. At current valuations (-34.7% from ATH), the risk/reward is balanced, not skewed. This is a Hold until margin recovery is proven in H2/Mar 2027. The number to track is not revenue (secure), but H2 EBITDA margin—if it improves to 8%+ and receivables normalize, equity risk/reward tilts. Until then, caution.
Fabtech delivered a headline-grabbing quarter (75% revenue growth, ₹468 Cr order book) but profitability lagged dramatically (55% PAT growth, flat 7.7% margin). This is execution-at-scale risk masquerading as growth. The long-term opportunity is real: the cleanroom market is growing 50-70% annually, and Fabtech's target to capture 25-30% market share by 2030 is credible. But the near-term risks (margin recovery, working capital normalization, order execution) must resolve by Mar 2027 for valuations to recover. The stock's -34.7% drawdown from ATH may be overcorrection, but it's not yet a screaming buy. Watch H2 margin and collections—they're the keys to resolving the tension between headline growth and actual profitability.
Ambitious growth plan, but execution gaps and margin headwinds temper near-term upside
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Hit revenue growth targets (75% vs guided 20-30%). Order book grew 2.3x. Margin guidance ambiguous (internally 8-10% target, externally 'same as H1' = 7.7%); PAT growth lagged volume growth.
Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Fabtech is executing a bold scaling strategy with a credible long-term vision (₹1,250 Cr order book potential, ₹25-30k Cr cleanroom market growing 50-70% annually, target #1 player by 2030). H1 delivered 75% revenue growth and secured record ₹468 Cr order book. However, profitability lagged volume growth (55% PAT growth vs 75% revenue growth), margins stayed flat at 7.7% despite inflation, and ₹40 Cr slippage between book and H1 execution reveals delivery constraints. Near-term margin recovery and H2 cash collection are critical de-risks.
₹133.23 Cr
Revenue · +75% YoY₹5.15 Cr
Reported PAT · +55% YoYFlat
Margins · vs guidance: MixedDid the claims hold up?
Revenue grew 75% in H1
METConsolidated revenue ₹133.23 Cr vs ~₹76 Cr prior year H1 = 75% growth confirmed
PAT growth 55%+ in H1
METPAT ₹5.15 Cr; prior year ~₹3.3 Cr (implied from 4+18 paise EPS) = ~55% growth
EBITDA margin 7.7% in H1, same as prior year
METEBITDA ₹10.28 Cr / Revenue ₹133.23 Cr = 7.7%. Maintained level despite inflation
Order book doubled to ₹468 Cr
METOrder book ₹468 Cr at 30 Sept vs ~₹200 Cr in March = 2.3x increase
Margins to improve in H2
OVERSTATEDManagement states 'PAT in H2 to exceed H1 fairly substantially' but margin driver unclear given inflation pressure. Dependent on achieving 70-80% growth & order execution
Earnings quality
What changed since the last call
Growth guidance revised upward internally
UpgradeInitial conservative 20-30% FY27 guidance revised to 70-80% internally, based on ₹468 Cr order book acceleration. However, externally guided cautiously to 20-30% for H2 (after H1 challenges).
Margin outlook flipped to caution
DowngradePrior call implied margin expansion from 7.6% (prior H1) to higher territory. H1 delivered 7.7% (flat), blamed on raw material inflation, geopolitical issues, lower-margin reference projects. H2 margin recovery now contingent on order mix & input cost stabilization.
Order book quality flagged
NewOrder book grew 2.3x to ₹468 Cr, but execution gap of ₹40 Cr revealed during call. Management acknowledged customers not ready for deliveries; orders conditional on customer readiness.
Data center & semiconductor opportunity elevated
UpgradeNew emphasis on India Semiconductor Mission, data center opportunity (Kelvin partnership, 50+ projects), expected to drive higher-margin orders. Pharma/life sciences margin pressure being offset by emerging verticals.
The Q&A
Analysts pressed hard on margin trajectory (Piyush Bisani, Ujival), order book quality (Ujival's ₹40 Cr reconciliation), execution detail (Amit Jain's design finalization timelines), capex needs (Sanjay Shah), and competitive intensity (Darshil). Management held ground defensively on margins ('war is behind us,' prices easing), acknowledged execution challenges candidly, but offered limited specificity on FY27 vs FY28 margin trajectory—relying on H2 > H1 PAT assertion rather than margin targets.
Order book execution timeline — Darshil Jhaveri
PartialExecution in 3 months feasible if customers ready. 200 Cr out of 468 expected to deliver next few months. Rest carried forward selective on better terms.
Margin target guidance — Darshil Jhaveri
PartialInternal target 8-10% PAT margin. H1 at 7.7% EBITDA. Expect H2 to exceed H1 fairly substantially on margin recovery.
Competitive position & market dynamics — Darshil Jhaveri
PartialFabtech building 100+ cleanroom classes, deepening expertise on HEPA/ALPA/VLSI, customer relationships. Will see competitive pressure but confidence in market size and technical moat.
Order book reconciliation — Ujival
AnsweredGap due to customers not ready to accept deliveries despite design finalization. Some orders conditional; customers need buildings to be ready first. This is learning from execution.
EBITDA margin trajectory H2 — Ujival
PartialExpected operating leverage as volumes rise, input costs settle. Will be higher than last year H2. Same percent growth margins expected going forward.
Data center opportunity sizing — Ujival
PartialIndia targeting 8-10 gigawatts by 2030. Kelvin partnership underway. ₹120 Cr Kelvin pipeline; solar & semiconductor also targeted. Building capabilities in high-precision cooling, cleanroom design.
Market share ambition realism — Ujival
AnsweredMarket is huge, growing 50-70% annually. Fabtech has 600 Cr hot pipeline, new facilities, partnerships (Kelvin, Avantech, Aart). Japanese competitor has ₹1,300 Cr revenue; Fabtech can reach top 3 in India by FY27, #1 by 2030.
Capex & working capital needs — Sanjay Shah
PartialDiscussions underway, likely capex needed. Banks have enhanced credit lines. Collections from current projects will ease working capital by Mar 2027. Not expecting to dilute equity.
Order position & billing rhythm — Amit Jain
AnsweredOrders managed by customer delivery readiness. Design approval + manufacturing + testing cycle ~3-8 weeks. Some delays due to customer building readiness or design changes.
Margin recovery assumptions H2 — Piyush Bisani
PartialWar-driven inflation easing, reference projects ending (which were lower-margin). New orders on better commercial terms. Strike price hedging in place for raw materials. Expect margins same as H1 going forward.
Margin headwinds persistence — Piyush Bisani
AnsweredHedging through customer contracts, building relationships for flexible pricing. Over time, costs will pass through. Currently absorbing some pressure.
Guidance
FY27 70-80% growth (internal target, conservative 20-30% guided externally for H2)
MediumOrder book ₹468 Cr can support 70-80% growth if execution & customer readiness align. H1 delivered 75% growth on ₹133 Cr, so FY27 could reach ₹240+ Cr full year.
PAT margin target 8-10% internally; FY27 expected at 7.7% (H1 level) going forward
LowH1 at 7.7%, not improved. Raw material inflation, reference projects at lower margins, geopolitical pressure offset scale. H2 margin recovery contingent on order mix shift & input stabilization.
EBITDA margin to remain 7.7% or improve modestly in H2
LowManagement hedged with 'same as H1' statement. Price increases easing, reference projects ending, but competitive pressure & capex intensity may cap upside.
Capex under discussion; banks enhanced credit lines; no external capital raise planned
MediumHyderabad facility operational, additional capacity (Kelvin partnership, Avantech in south) being planned. Working capital tied up in receivables; capex likely needed for FY28+ growth.
Risks the call surfaced
Execution Risk
Medium₹468 Cr order book but H1 execution only ~₹130 Cr revenue; ~₹40 Cr gap attributed to customer building readiness and design changes. Scaling from ₹130 Cr H1 to ₹200+ Cr H2 requires operational acceleration.
Profitability Risk
MediumH1 EBITDA margin flat at 7.7% despite 75% revenue growth; PAT growth 55% lagged volume growth. Aluminum prices jumped 220→440 rupees in 2 months. Reference projects (Awaree) at lower margins to build credentials.
Working Capital Risk
MediumReceivables ₹129 Cr represent 97% of H1 revenue (₹133 Cr). Management tied to milestone-linked collections from reference projects; improvement expected by Mar-2027 but near-term cash flow pressure.
Market Competition
MediumCleanroom market growing 50-70% annually (~₹25-30k Cr market), attracting established competitors. Daikin (Japan) has ₹1,300 Cr revenue. Fabtech current market share ~5% (₹5,000 Cr market share of total).
Geopolitical & Supply Chain Risk
HighAluminum, steel, rockwool, powder coating materials subject to geopolitical disruption. Prices swung unpredictably (aluminum +100% in 2 months). Management acknowledged 'unpredictable' cost environment in H1.
Capital Intensity
MediumGrowth target 70-80% FY27 + ambition to reach ₹1,000+ Cr revenue by 2030 requires significant capex. Hyderabad facility operational, but data center/semiconductor opportunities need further investment.
Management
Score 7/10. Asif Khan (CEO) and Anup Munshi (COO) communicated boldly on long-term vision (₹1,000+ Cr by 2030, #1 player by 2030) and acknowledged execution challenges candidly (customer readiness delays, input cost volatility). However, margin guidance was ambiguous—internally 8-10% target, externally 'same as H1' (7.7%), creating confusion. Addressed analyst pushback reasonably but sometimes deflected on specifics (capex timeline, H2 margin assumptions). Track record mixed. FY26→FY27 H1 revenue growth exceeded guidance (75% actual vs ~20-30% guided). Order book accelerated 2.3x to ₹468 Cr. However, H1 margins flat (7.7%) despite scale, and execution delivery lagged order book by ~₹40 Cr. PAT growth (55%) slower than revenue growth (75%). Team acknowledged learning curve and execution constraints; improvements planned.
1 · H2 FY27 (Jan-Mar 2027)
Execution of ₹468 Cr order book, milestone collections on ₹129 Cr receivables, PAT to exceed H1
2 · FY28 (Apr 2027+)
Hyderabad 50k sqm facility operational, targeting semiconductor & data center cleanroom orders
3 · Sep 2027+
Kelvin data center reference project completion; unlock ₹120 Cr pipeline in data centers
Near-term margin recovery and H2 cash collection are critical de-risks.